Dogwood Therapeutics, Inc.
DWTX
$1.84
$0.010.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -28.32M | -34.26M | -38.20M | -24.74M | -21.98M |
| Total Depreciation and Amortization | 68.00K | 68.20K | 63.80K | 46.50K | 29.20K |
| Total Amortization of Deferred Charges | 0.00 | 52.40K | 110.80K | 110.80K | 110.80K |
| Total Other Non-Cash Items | 12.73M | 18.65M | 22.26M | 10.26M | 10.35M |
| Change in Net Operating Assets | -2.80K | -133.00K | -2.34M | -1.42M | -1.04M |
| Cash from Operations | -15.52M | -15.62M | -18.11M | -15.75M | -12.54M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 3.76M | 3.76M | 3.76M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 3.76M | 3.76M | 3.76M |
| Total Debt Issued | 0.00 | 3.00M | 18.32M | 18.32M | 18.32M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11.48M | 4.46M | 4.37M | 4.37M | 5.82M |
| Repurchase of Common Stock | -226.40K | -120.10K | -120.50K | -190.70K | -70.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -53.80K | -53.80K | -- | -- | -- |
| Cash from Financing | 11.20M | 7.28M | 22.57M | 22.50M | 24.08M |
| Foreign Exchange rate Adjustments | 8.50K | 10.70K | -136.60K | -133.30K | -143.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.31M | -8.32M | 8.09M | 10.38M | 15.16M |